Business
NYT Connections Puzzle #1085 for May 31, 2026 Delivers Colorful Mix of Yellow Icons, Billiards and Slang
NEW YORK — The New York Times Connections puzzle for Sunday, May 31, 2026, challenged players with a vibrant blend of everyday icons, sports terminology and clever wordplay, as solvers grouped 16 words into four thematic categories in the popular daily brain teaser.
Puzzle No. 1085 featured categories ranging from bright yellow objects to billiards equipment, sailor slang and a punny take on wood types. The solution encouraged both casual players and dedicated fans to think laterally across pop culture, sports and language.
Yellow Category (Easiest): Things That Are Yellow — Butter, Pikachu, Rubber Duck, School Bus. Green Category: Billiards Terms — Break, Cue, Pocket, Rack. Blue Category: Slang For Sailor — Jack, Salt, Sea Dog, Tar. Purple Category (Hardest): Kinds Of Wood Plus “S” — Sash (ash), Soak (oak), Spine (pine), Steak (teak).
The puzzle’s yellow group stood out for its visual appeal, connecting classic symbols of the color yellow. Pikachu, the beloved Pokémon character known for its electric yellow fur, joined childhood staples like the rubber duck and school bus, alongside the common food item butter.
Game Mechanics and Growing Popularity
Connections, created by Josh Wardle and acquired by The New York Times, requires players to sort 16 words into four groups of four based on shared themes. Correct groupings earn color-coded feedback: yellow for the simplest, followed by green, blue and purple for the most challenging.
Since its debut, the game has built a loyal audience alongside Wordle and other NYT Games offerings. Its appeal lies in the balance of straightforward associations and trickier lateral thinking, often sparking discussions on social media about missed connections or clever reveals.
On May 31, 2026, many players noted the puzzle’s accessible yet engaging difficulty. The billiards category tested knowledge of pool terminology, where “break” refers to the opening shot, “cue” is the stick, “pocket” the target and “rack” the triangular setup of balls.
The blue category highlighted nautical slang with historical roots. “Tar” and “salt” evoke old seafaring terms, while “sea dog” describes an experienced sailor and “jack” appears in phrases like “jack tar.”
The purple category provided the day’s wordplay twist, adding “S” to wood types: ash becomes sash, oak becomes soak, pine becomes spine, and teak becomes steak. This type of pun often separates strong solvers from others.
Player Reactions and Strategies
Social media and puzzle forums buzzed with reactions throughout the day. Many appreciated the yellow category’s straightforward nature, while others struggled with the purple group’s linguistic trick.
Effective strategies for Connections include scanning for obvious clusters first, such as colors, sports terms or professions, before tackling subtler links. Starting with potential categories like billiards or yellow objects often unlocks the grid efficiently.
Players in Seoul and other international hubs frequently engage during evening hours, turning the daily puzzle into a shared cultural ritual that blends English vocabulary practice with entertainment.
Broader Context in NYT Games
Connections joins a robust lineup from The New York Times Games team, which carefully curates puzzles to maintain freshness and fairness. Each daily edition offers a new challenge at midnight local time, fostering global participation across time zones.
The game’s design rewards diverse knowledge — from Pokémon to maritime history and woodworking puns — making it both educational and fun. Solvers often report improved pattern recognition and lateral thinking skills over time.
Past puzzles have covered topics from food and music to history and science, demonstrating the team’s broad vocabulary and thematic creativity. Puzzle No. 1085 exemplified this range with its mix of playful and technical categories.
Tips for Mastering Connections
Experts suggest several approaches for consistent success:
- Look for super obvious groups first, like colors or common phrases.
- Consider multiple meanings of words — “salt” can be a seasoning or a sailor.
- Pay attention to wordplay, especially in harder purple categories.
- Use the mistake limit strategically; three errors end the game.
- Practice daily to build intuition for common category types.
For Sunday’s puzzle, identifying the yellow items early often provided momentum, while the sailor slang required some nautical familiarity or process of elimination.
Cultural Impact and Community
In South Korea, where English learning remains a priority, Connections serves as both entertainment and a learning tool. Players frequently discuss solutions in online communities, sharing strategies and celebrating streaks.
The game’s accessibility — available through NYT subscription or limited free plays — has helped sustain its popularity years after launch. Families and friends compete to see who can solve fastest, creating bonding moments around shared puzzles.
Unlike more solitary games, Connections sparks conversation. Players post their grids online, comparing attempts and laughing over near-misses with the purple category’s wood puns.
Looking Forward
As May 31 drew to a close, attention turned to Monday’s puzzle, promising fresh challenges. The New York Times continues refining Connections with occasional special editions and ties to other games in its portfolio.
For those who solved No. 1085 perfectly, the satisfaction came from connecting seemingly random words into coherent themes. Even those who needed hints appreciated the puzzle’s clever construction.
The enduring appeal of Connections lies in its simplicity and depth. A single grid of 16 words can transport players from childhood memories of yellow school buses to the felt tables of billiards halls and the decks of old sailing ships.
As millions reset for the next puzzle, Sunday’s edition left a colorful impression — a reminder of how word games continue to unite players through shared curiosity and mental agility.
The NYT Games team selects words to ensure solvability while maintaining challenge, contributing to the franchise’s strong reputation for quality and fairness.
Scott Kaufman, aka Treading Softly, learned about investing firsthand from over a decade of financial sector experience. He is the lead analyst for Dividend Kings providing actionable insight into high quality dividend growing and undervalued opportunities. His focus is to see a bountiful harvest of cash dividends and strong capital gains, providing a robust total return.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Kody’s Dividends, Justin Law, and Rachel Kaufman are part of the Dividend Kings team
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress disorder.
Now, she says the psychoactive drug more commonly known as ecstasy or molly has changed the trajectory of her life.
“My experience of MDMA was that it just cracked my heart wide open,” said Phelan who enlisted in the U.S. Army Reserve in 1999 and was deployed to Iraq in 2003.
“I was carrying this big heavy rucksack and I just put it down on the beach and I started unpacking it one little teeny tiny thing at a time and setting each little thing out on the waves,” Phelan said of the release from the treatment.
Phelan isn’t alone turning to alternative treatments for trauma. She is among a small group of Americans who have undergone psychedelic-assisted therapy through clinical trials studying new approaches to mental health treatment.
Now, access to those therapies is closer than ever to being expanded more broadly, bringing new options for patients and opportunities for companies — but also new scrutiny about safety and effectiveness.
In April, President Donald Trump signed an executive order aimed at accelerating research into psychedelic drugs for mental illness. The move came as his administration issued priority review vouchers to three companies developing psychedelic or MDMA-like therapies — Compass Pathways, Usona Institute and Transcend Therapeutics — aimed at speeding up parts of the FDA review process.
The order marks a notable shift in tone from Trump’s first term, when his administration took a harder stance on cannabis and other controlled substances. This time, the White House said psychedelic compounds “show potential in clinical studies to address serious mental illnesses for patients whose conditions persist after after completing standard therapy.”
U.S. President Donald Trump signs an executive order on researching the effects of psychedelic drugs in medical treatment for veterans, on Saturday, April 18, 2026 in the Oval Office at the White House in Washington, D.C.
The Washington Post | The Washington Post | Getty Images
Investors quickly piled into the sector. Shares of psychedelic drug developers such as Compass Pathways and other rivals tied to the space rallied following the announcement, with Wall Street analysts arguing the order could legitimize an industry long viewed as fringe.
The science, however, remains deeply debated, raising questions about how much room the segment has to grow.
Inside the lab
Historically, research into psychedelics has focused more narrowly on certain conditions. Psilocybin — the active compound in psychedelic mushrooms — was tied to treating depression, MDMA-assisted therapy to PTSD and LSD to anxiety.
While drugs like psilocybin and ibogaine — a psychoactive compound derived from a West African shrub that some advocates believe may help treat addiction and traumatic brain injuries — are considered classic psychedelics, MDMA is technically classified as an empathogen.
Still, researchers and regulators often group MDMA-assisted therapy within the broader psychedelic medicine field because the treatments involve supervised therapeutic sessions designed to address conditions like PTSD, depression and addiction.
“One of the things that’s important to recognize is these are all very different drugs,” said Brandon Weiss, a researcher at the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine. “Ibogaine and other psychedelic compounds have different safety profiles and different risks.”
FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency in Washington, May 7, 2019.
DEA | Reuters
Clinical research around some of these compounds has shown promising results. In late-stage trials sponsored by the nonprofit psychedelic research advocacy group Multidisciplinary Association for Psychedelic Studies, roughly 71% of participants with severe PTSD no longer met diagnostic criteria for the disorder after MDMA-assisted therapy sessions.
The FDA rejected a previous application for MDMA-assisted therapy in 2024, citing concerns around the design of that same late-stage study and the need for additional data. Some psychedelic researchers viewed that decision as evidence the agency remains cautious despite mounting public enthusiasm.
Countries outside the United States have already begun loosening restrictions. Australia became the first country to allow authorized psychiatrists to prescribe MDMA and psilocybin for certain mental health conditions in 2023. Researchers in Canada, Switzerland and the United Kingdom have also expanded clinical studies examining psychedelic-assisted therapies.
Even so, Weiss cautions that not all psychedelic compounds carry the same risks — or the same amount of evidence supporting their use.
“Psychedelic compounds, they have different safety profiles, different risks,” said Weiss. “Ibogaine has particularly high cardiovascular risks, and so what needs to be done is a very measured, methodical weighting of the safety and the efficacy between ibogaine and other compounds.”
The White House executive order specifically referenced accelerating research of ibogaine. But unlike psilocybin or MDMA-assisted therapy, ibogaine has not undergone large-scale clinical trials in the United States and has been linked to potentially serious cardiovascular side effects.
Weiss said the real worry among some researchers is not that psychedelic therapies are ineffective, but that political momentum could outpace the scientific process.
“My biggest concern would be that FDA standards are relaxed for politically motivated reasons,” he said. “It’s not clear that that is the case, but what’s required is a lot more scientific research and a very objective interpretation of the risks and benefits.”
Kabir Nath, Compass Pathways CEO, said his company is adhering to the same standards the FDA holds for all drugs. He said the company would not have started the process of submitting its drug, COMP360 Psilocybin, for approval in the first place if it felt the data was insufficient.
Even supporters of psychedelics used as treatment acknowledge the therapies are far more complex than taking a prescription pill at home. Most psychedelic-assisted therapy trials involve hours of preparation with clinicians, supervised treatment sessions and follow-up integration therapy afterward.
The treatments also come with risks. Patients can experience panic attacks, paranoia, elevated heart rates or psychological distress during sessions. In some clinical environments, doctors use so called “rescue drugs” like benzodiazepines or antipsychotic medications to calm patients experiencing severe adverse reactions or overwhelming hallucinations.
Phelan said her own experience with MDMA-assisted therapy felt less like intoxication and more like confronting years of trauma in a controlled setting.
For veterans’ advocates like Juliana Mercer, executive director of nonprofit Healing Breakthrough, the administration’s order represents validation for patients who have spent years pushing for broader access to alternative mental health treatments. Mercer, a U.S. Marine Corps veteran, said psychedelic-assisted therapy “completely changed” her life after she struggled with trauma.
“One of the things that this experience was able to give me was that permission to heal,” said Mercer.
Why now?
As the Trump administration pursues VA staffing cuts and deeper military involvement with Iran, some veterans are increasingly questioning the prioritization of their care.
Thus, some critics of the Trump administration have said that the executive order’s timing is of particular importance as the president attempts to gain back veteran support ahead of the midterm elections.
Phelan, however, rejected the idea that backing for psychedelic therapies will translate into into political support for Trump.
“They’d made so many cuts to veteran benefits and medical services,” Phelan said. “Great, you did a good thing. You did a right thing … I can’t speak for how other people will react, but if that’s the intention, I doubt it’s effective.”
Some industry executives also argue the executive order may have less immediate impact than headlines suggest. Companies like Compass Pathways were already nearing the final stage of Phase 3 trials before the White House announcement, meaning FDA approval submissions were likely coming regardless.
Nath, CEO or Compass Pathways, said the order primarily signals broader political acceptance of the field.
“It certainly gives a significant tailwind, encouragement and validation,” Nath said.
— CNBC’s Ryan Baker contributed to this report
Zepto’s shares, which were changing hands at around Rs 52 in the unlisted market a month ago, have dropped to about Rs 40, according to dealers tracking pre-IPO transactions.
The decline comes even as the quick commerce startup recently received approval from Sebi to launch its much-awaited public issue. The company had taken the confidential route to file the DRHP but may soon file its papers publicly in June, according to Bloomberg.
Analysts said the fall reflects weakness in the unlisted market and a broader reassessment of valuations rather than any company-specific development. The company is being valued at around Rs 38,000 crore in the dealer market.
Several companies that had planned public offerings this year have either delayed listings or adopted a wait-and-watch approach because of volatility in equity markets, geopolitical tensions and uncertainty around investor demand.
The benchmark Nifty has remained under pressure for much of 2026, while foreign institutional investors have continued to remain cautious on Indian equities amid concerns over crude oil prices, global growth and the earnings outlook.
The weakness in the secondary market for pre-IPO shares has also affected several startup names, with investors becoming more selective on valuations after a strong rally in the segment over the past two years.Zepto is preparing for a public market debut that could raise around $1.3 billion, or roughly Rs 11,000-12,000 crore, making it one of the largest internet IPOs since the listing of Swiggy.
If the issue proceeds as planned, Zepto could become the youngest venture-backed Indian startup to enter public markets, just four years after its founding.
The proposed offering is expected to comprise a substantial fresh issue of around Rs 11,000 crore along with an offer-for-sale component by existing investors.
The IPO assumes significance because it comes amid intensifying competition in India’s fast-growing quick commerce sector.
Zepto competes with Blinkit, owned by Eternal, as well as Swiggy Instamart, Flipkart Minutes and Amazon Now.
The listing is also expected to strengthen the company’s balance sheet at a time when the quick commerce industry continues to spend aggressively on expansion, dark stores and customer acquisition.
As of late last year, Zepto had around Rs 7,000 crore in cash, significantly lower than the roughly Rs 17,000-18,000 crore cash reserves reported by listed rivals Eternal and Swiggy.
The company raised $450 million in October last year at a valuation of $7 billion. Following the fundraise, it accelerated customer acquisition efforts through higher discounts and promotional campaigns as competition intensified across major cities.
Zepto had also completed its domicile shift from Singapore to India, a move increasingly adopted by venture-backed startups preparing for domestic listings.
The company has appointed a consortium of investment bankers including Morgan Stanley, HSBC, Goldman Sachs, Axis Capital, JM Financial, IIFL Securities and Motilal Oswal Financial Services to manage the public issue. The IPO is expected to hit the market in the July-September quarter of 2026.
While the recent decline in the unlisted share price may reflect near-term market caution, investors will closely watch the final valuation and broader market conditions when Zepto eventually launches what is expected to be one of the year’s most closely watched public offerings.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Experimental Novartis radiopharma drug shows promise in early study
“The findings of Sebi in the said order are related to the financial statements of the company from FY14 to FY18. The company will be filing an appeal before the Securities Appellate Tribunal in respect of the Sebi order,” the company said.
The development comes a day after Sebi imposed penalties on Suzlon and a number of former senior executives following a long-running investigation into the company’s historical financial reporting practices.
The market regulator levied a penalty of Rs 15.95 crore on Suzlon, while former executive Vinod R Tanti was fined Rs 5.75 crore and Girish R. Tanti was penalised Rs 5.45 crore. Former group CFO Kirti J. Vagadia was fined Rs 1.5 crore, while former CFO Amit Agarwal was directed to pay Rs 30 lakh.
Sebi action followed a forensic audit and investigation covering multiple financial years after the regulator received a complaint alleging irregularities in dealings involving subsidiaries and associate entities.
The regulator concluded that certain transactions between Suzlon and its subsidiaries had the effect of overstating profits and strengthening the appearance of the company’s financial position.
Among the issues examined were transfers of businesses and investments among group entities, accounting treatment of contingent liabilities, impairment reversals and disclosures made in financial statements.According to Sebi, some transactions involving subsidiaries resulted in substantial accounting gains being recorded without reflecting the underlying economic reality of the arrangements. The regulator also questioned the treatment of certain liabilities and fund flows between group entities, concluding that the company’s disclosures did not present a true and fair picture of its financial position during the period under review.
Sebi said accurate financial statements are critical because investors rely on them while assessing the health and prospects of listed companies. The regulator held that the violations warranted monetary penalties under provisions relating to disclosure norms, listing regulations and fraudulent and unfair trade practices.
Suzlon, however, has now moved to contest the findings before the appellate tribunal.
The company has undergone a significant turnaround over the past few years after overcoming a prolonged debt crisis and has emerged as one of the biggest beneficiaries of India’s renewable energy push. It recently reported strong operational performance and remains one of the country’s largest wind energy equipment manufacturers.
The appeal before the SAT will determine whether the regulator’s findings and penalties are upheld, modified or set aside. Until then, the Sebi order remains in force.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times.)
Check out what’s clicking on FoxBusiness.com.
A frozen cheese bread product sold at Costco is being recalled over concerns it could be contaminated with salmonella, prompting the retailer to notify customers who purchased the affected items.
Champion Foods LLC announced a voluntary recall of certain batches of Motor City Pizza Co. 5 Cheese Bread after learning that an ingredient supplier had recalled milk powder because of a potential salmonella contamination concern.
According to the company, the recalled milk powder was supplied to a third-party manufacturer that produces a seasoning blend used in the product’s five-cheese sauce mixture.
Costco also sent notices to members who purchased the product, saying its records indicate they, or one of their add-on members, bought Motor City Pizza Co. 5 Cheese Bread between Feb. 6 and May 29. The wholesale club advised customers not to consume the recalled product and to return it to a local Costco warehouse for a full refund.
DELI MEAT, CUCUMBERS TOP LIST OF ‘REALLY RISKY FOODS’ YOU MIGHT HAVE IN THE FRIDGE
Champion Foods LLC announced a voluntary recall of its Motor City Pizza Co. 5 Cheese Bread, which is sold at Costco, over potential salmonella concerns. (Champion Foods / Unknown)
The recall affects both single-pack and two-pack versions of the frozen bread product.
The affected single-pack product carries UPC code 8 70375 00511 1 and includes sell-by dates ranging from Feb. 4, 2027, through April 21, 2027.
The affected two-pack product carries UPC code 8 70375 00509 8 and includes sell-by dates of Feb. 3, 2027; Feb. 4, 2027; Feb. 24, 2027; Feb. 25, 2027; March 10, 2027; March 11, 2027; March 18, 2027; and March 25, 2027.
Costco sent a letter to members about the recalled product. (Joe Raedle/Getty Images / Getty Images)
5 OF THE TOP SOURCES OF FOODBORNE ILLNESS AND HOW TO PREVENT IT
Champion Foods said routine testing conducted by the seasoning blend manufacturer before the ingredient was used in production showed the batches tested negative for salmonella. The company said it nevertheless decided to issue the recall “out of an abundance of caution” for customer safety.
Costco urged consumers who purchased one of the recalled products to not eat it and return it to Costco for a refund. (Joe Raedle/Getty Images / Getty Images)
Costco’s notice stated that no illnesses or injuries related to the recalled products have been reported.
Salmonella is an organism which can cause “serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems,” according to the U.S. Food and Drug Administration (FDA). Symptoms among healthy individuals may include fever, diarrhea, nausea, vomiting and abdominal pain.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
In rare and more serious cases, salmonella can spread to the bloodstream, potentially causing arterial infections, endocarditis or arthritis.
FOX Business’ Bonny Chu contributed to this report.
How Trump’s Ukraine aid cuts undermine justice for Russian war crimes
Business
Market Trading Guide: YES Bank among two stock picks for Monday with up to 10% upside scope
Analysts say that in the near term, investor attention is expected to shift toward key domestic triggers, particularly the upcoming RBI monetary policy decision and GDP data release, which will provide further insights into the inflation trajectory and overall economic momentum.
Here are two stocks to buy on Monday
1) YES Bank – Buy | CMP: Rs 23.22 | Stop loss: Rs 22.5 | Target: Rs 25
Yes Bank shows strong bullish momentum as the price breaks decisively above the key horizontal resistance level at Rs 22.02. This breakout is supported by a noticeable volume expansion, confirming genuine market participation. The price is trading cleanly above the short- and long-term EMAs, which are fanning out in a bullish alignment, while the RSI rises above 60, signalling accelerating upward strength toward the descending trendline.
2) NBCC – BUY | CMP: Rs 100.3 | SL – Rs 95 | Target – Rs 110
NBCC (India) Limited exhibits a strong bullish reversal as price breaks above multiple short-term EMAs and tests the long-term blue EMA near 101.30. This upward shift is backed by a notable volume surge, indicating a clear influx of buyers at these levels. Meanwhile, the RSI has crossed above the 60 threshold, signalling accelerating positive momentum and confirming a strong structural turnaround from the recent bottom
(Virat Jagad is Sr Technical Research Analyst at Bonanza Portfolio)(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times.)
Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with expertise in the technology, energy, industrials, and materials sectors. Prior to working in the investment management industry, Michael spent over a decade in professional services working across industries that include O&G, OFS, Midstream, Industrials, Information Technology, EPC Services, and consumer discretionary.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of DELL, NVDA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
The Private Credit, Subprime Comparison Is Intuitive. It’s Also Wrong.
Ireland’s explosive data centre growth triggers shocking rise in electricity bills
NBA Playoffs: Finals schedule, scores
Man arrrested for $31,000 iPhone theft
-
Business7 days agoNYT Strands Answers May 24 2026 Revealed for Puzzle No. 812 Theme Summer Essentials
-
NewsBeat4 days agoIsrael says it has killed new Hamas military leader in Gaza City airstrikes
-
Tech4 days agoNASA taps Blue Origin to deliver lunar rovers for Moon Base initiative
-
Politics6 days agoBridgerton Season 5: Cast, Release Date And Everything We Know So Far
-
News Videos4 days agoXRP *JUST* SUCCEEDED!!!! CLARITY ACT EXPOSED!!! (SHE EXPOSED IT)
-
Sports5 days ago2026 NBA Finals schedule, odds: Knicks await Thunder or Spurs after winning East
-
Business4 days agoSelena Gomez Reportedly Upset Over Benny Blanco’s Comments on Her ‘Terrible’ Diet
-
Crypto World5 days agoMicron Crosses $1 Trillion Market Cap as AI Demand Reshapes Memory Sector
-
Crypto World7 days ago
Brian Armstrong Outlines Crypto Vision for the Future Financial System
-
News Videos2 days agoThis is BROKEN! INSANE 5x MONEY CAR WASH WEEK! The NEW GTA Online UPDATE Today! (GTA5 New Update)
-
Business6 days agoBTS Sells Out Four Las Vegas Shows at Allegiant Stadium for ARIRANG World Tour
-
Tech5 days agoChina assigns ID codes to 28,000+ humanoid robots
-
NewsBeat6 days agoHottest May day ever as London hits 34.8C in 2C leap from previous records
-
Tech6 days agoMicrosoft’s quiet Claude Code retreat and the real cost of enterprise AI
-
Tech2 days agoWaymo dominates autonomous vehicle registrations as Tesla trails behind
-
Business6 days agoNikkei 225 Surges Past 65,000 for First Time as Iran Peace Hopes Fuel Record Rally
-
Tech4 days ago
The Samsung pay deal is the moment Korean unions changed register
-
Tech6 days agoWestone Audio and Etymotic Acquired by Fidelity Collective in Major IEM Market Move
-
Entertainment5 days ago‘Breaking Bad’ Star’s Easy-to-Binge 6-Part Crime Series Spin-Off Is Finally Heading to Free Streaming
-
NewsBeat6 days agoCrowds find riverside shade in York as temperatures soar
You must be logged in to post a comment Login